Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

More Potential for Web-based Clinical Trial Document Exchange

By Drug Discovery Trends Editor | June 25, 2012

The results of the 2012 IntraLinks Global Investigator Site Survey revealed an increased prevalence in the use of online tools from 65% in 2011 to 74% in 2012, but that there is a significant opportunity for investigator sites to improve efficiency through web-based solutions for clinical trial exchange. The survey looked at what methods are currently used for clinical trial document exchange, and the effectiveness of those methods.


The survey findings show that the majority of investigator sites are using traditional methods—email, courier and fax—as a primary tool for clinical trial document exchange. Adoption of electronic tools has grown, yet these methods continue to fall short in addressing the current document exchange needs at most clinical trial sites:


• 77% of respondents (a 4% increase over the 2011 survey) use traditional methods—email (64%), courier (8%), and fax (5%)—as their primary tool for clinical trial document exchange
• 20% of respondents use web-based document exchange tools including electronic data capture technologies (85%) and clinical portals (83%) as their main way of exchanging clinical trial documents
• 3% of respondents didn’t select a primary method


The survey results indicate that investigator sites are experiencing significant inefficiencies and productivity challenges as a result of the ongoing use of email, courier, and fax:
• 58% of respondents track due dates for information, current status, or milestones manually
• 66% of respondents spend at least two hours, and in some cases more than nine hours, per week searching for documents
• 78% of respondents (up 4% from 2011) report resending documents to sponsors and contract research organizations (CROs) at least once or twice, and in some cases more than five times, a week


The survey found that respondents recognize the benefits of web-based clinical document exchange tools:
• 71% of respondents cited being able to access updated information right away and reducing the amount of paper they use as advantages
• 60% of respondents cited being able to keep track of information easily as a benefit
• 49% of respondents cited not spending as much time searching for information as a benefit


The survey results also showed that most respondents are conducting numerous studies and those that use online clinical tools such as electronic data capture and clinical portals have a significant number of passwords and logins:
• 89% of respondents have conducted three to 15+ studies over the last 12 months
• 53% of respondents are running four to 15+ concurrent studies
• 83% of respondents use online clinical trial portals, up from 71 percent in 2011


“There needs to be a paradigm shift to evaluate clinical document exchange challenges from a clinical community perspective,” said George Waidell, VP, life sciences practice at IntraLinks. “It is pivotal for sponsors and CROs to consider investigator sites’ needs and the clinical community perspective. Deploying web-based clinical document exchange tools will enable them to reach optimal productivity gains and efficiencies.”


The IntraLinks Global Investigator Site Survey was conducted online by CenterWatch, a trusted source of clinical trials information for both professionals and patients. There were 600 responses to the survey with 71% of respondents based in North America, 19% in Europe, and 5% in Asia Pacific. For more information on the survey, contact your IntraLinks representative.


IntraLinks is exhibiting at DIA’s 48th Annual Meeting in Philadelphia from June 24–28 at booth 3131.


Release Date: June 18, 2012
Source: Intralinks


Filed Under: Drug Discovery

 

Related Articles Read More >

Pharma 2035 Playbook: Speed, focus and conviction in an uncertain world
TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE